ReleaseWire Connect

Nonalcoholic Drinks Market Report, published by Allied Market Research, forecasts that the global market was valued at $1,548 billion in 2015, and is estimated to reach $2,090 billion by 2022, growing at a CAGR of 4.4% from 2016 to 2022. The soft drinks segment is expected to retain its dominant position, in terms of revenue generation during the forecast period. The Asia-Pacific region held the leading position in the global market in 2015, and is expected to maintain its lead in the future.

Disposable gloves Market and is projected to reach $10,061.0 million by 2023 from $6,146.2 million, growing at a CAGR of 7.5% from 2017 to 2023. In 2016, the medical segment accounted for about three-fifths share of the global market.

According to a new report published by Allied Market Research, titled, Over the Counter (OTC) Drugs & Dietary Supplements Market by Category, Dosage Form, Product, and Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2017-2023," the global over the counter (OTC) drugs & dietary supplements market was valued at $223 million in 2016, and is projected to reach $335 million by 2023, growing at a CAGR of 5.9% from 2017 to 2023. The vitamins and dietary supplements (VDS) segment accounted for maximum share of about half the global market share in 2016.

Although major market share is captured by few market players, the threat of new entrants is high in cleanroom disposable gloves industry due to low initial capital investment, high volume demand, lesser product differentiation and low-cost technology incorporated for manufacturing cleanroom disposable gloves, attracts many new players to enter the cleanroom disposable gloves market.

Gene Therapy Market is estimated to reach $4,402 million by 2023 from $584 million in 2016, registering a CAGR of 33.3% from 2017 to 2023. North America is the highest contributor in the gene therapy market in 2016; however, Asia-Pacific is expected to witness the highest growth rate during the forecast period.

Global Biosimilars Market (Follow-on-Biologics) by Types (Human growth hormone, Erythropoietin, Monoclonal antibodies, Insulin, Interferon, Granulocyte-Colony Stimulating Factor, Peptide), Application (Blood disorders, Oncology diseases, Growth hormone deficiencies) is projected to grow at a CAGR of 49.1% from 2015 to 2020, according to new research published by Allied Market Research.

The global Artificial intelligence (AI) in healthcare market was valued at $1,441 million in 2016, and is estimated to reach at $22,790 million by 2023, registering a CAGR of 48.7% from 2017 to 2023.

The global enteral feeding devices market was valued at $2,503 million in 2017 and is projected to reach $3,848 million by 2025 at a CAGR of 5.4% from 2018 to 2025. Enteral feeding is a method of delivering nutrition or medications directly in the stomach or intestine. Enteral feeding devices are commonly used to feed the specialized diets in elderly or bedridden patients suffering from chronic ailments, such as neurological disorders, cancer, gastrointestinal and inherited metabolic diseases. It is the preferred route of nutrition delivery as compared to parenteral feeding because enteral feeding avoids complications, such as infection, sepsis, liver & gallbladder disorders, and commonly associated with parenteral nutrition.

Global Oncology Information Systems Market were valued at $2,247 million in 2015, and is estimated to reach $3,755 million by 2022, registering a CAGR of 7.5% from 2016 to 2022. Across the healthcare settings, such as clinics, hospitals, and research laboratories, patient portfolios are managed by software termed as oncology information systems. In addition, this software is used to predict treatment outcomes, plan the patient's treatment accordingly, and exchange cancer patient information among the overall healthcare organizations. These advantages improve the safety and efficiency of cancer therapy for patients. Oncology information systems help physicians and surgeons to choose the most appropriate therapy to improve the survival rate of the cancer patients. The availability of a variety of cancer therapies, such as chemotherapy and radiation therapy, and presence of huge cancer population base are major factors that drive the market growth.